Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Capital Expenditures Growth (5y) (2026)

Analysis

Starling Oncology (STLN) Capital Expenditures Growth (5y) (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.41%
Mar 31, 2026 10.98%